Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine advanced pancreatic cancer


Yavuz A., Aydin F., Yavuz M., Ilis E., Ozdemir F.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol.51, no.4, pp.974-981, 2001 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51 Issue: 4
  • Publication Date: 2001
  • Doi Number: 10.1016/s0360-3016(01)01737-0
  • Journal Name: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.974-981

Abstract

Purpose: To determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT) of twice-weekly gemcitabine (TW-G) when administered in conjunction with fixed dose amifostine (A) during external radiotherapy (RT) in patients with advanced pancreatic cancer.